FX.co ★ Fresenius Medical Care Receives Mechanical Circulatory Support Agreement With Premier

Fresenius Medical Care AG, headquartered in Germany, announced on Tuesday that its heart and lung division has secured a national group purchasing agreement for Mechanical Circulatory Support with U.S.-based Premier, Inc. This agreement allows Premier's network of hospitals and health systems across the United States—and their patients—to access the Novalung System at preferential pricing and terms. The Novalung System is an FDA-approved device designed for long-term extracorporeal membrane oxygenation. As of the latest stock market update, Fresenius shares are trading at $21.91, reflecting a 0.95% decrease on the New York Stock Exchange.